181 related articles for article (PubMed ID: 15514942)
1. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma.
Zhou C; Liu S; Zhou X; Xue L; Quan L; Lu N; Zhang G; Bai J; Wang Y; Liu Z; Zhan Q; Zhu H; Xu N
Int J Cancer; 2005 Mar; 113(6):891-8. PubMed ID: 15514942
[TBL] [Abstract][Full Text] [Related]
2. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.
Yan S; Zhou C; Zhang W; Zhang G; Zhao X; Yang S; Wang Y; Lu N; Zhu H; Xu N
Cancer Lett; 2008 Nov; 271(1):85-97. PubMed ID: 18602747
[TBL] [Abstract][Full Text] [Related]
3. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
4. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
[TBL] [Abstract][Full Text] [Related]
6. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
Feng Y; Lee N; Fearon ER
Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
[TBL] [Abstract][Full Text] [Related]
7. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma.
Yan S; Zhou C; Lou X; Xiao Z; Zhu H; Wang Q; Wang Y; Lu N; He S; Zhan Q; Liu S; Xu N
Cancer Res; 2009 Apr; 69(8):3283-90. PubMed ID: 19351864
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
9. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
11. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
[TBL] [Abstract][Full Text] [Related]
13. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor.
Chesire DR; Isaacs WB
Oncogene; 2002 Dec; 21(55):8453-69. PubMed ID: 12466965
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
15. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.
Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y
Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang J; Yang Y; Chen L; Zheng D; Ma J
Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776
[TBL] [Abstract][Full Text] [Related]
17. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
[TBL] [Abstract][Full Text] [Related]
18. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription.
Hu MC; Rosenblum ND
Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399
[TBL] [Abstract][Full Text] [Related]
19. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of TCF4 expression as a transcriptional target of beta-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Lab Invest; 2005 Jun; 85(6):768-79. PubMed ID: 15806138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
